FDA Inspection 1029942 — CorePharma, LLC

CorePharma, LLC — FEI 3002535019

The FDA completed an inspection of CorePharma, LLC on October 13, 2017 in Middlesex, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 13, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Middlesex, NJ (United States)